BEST OF CMHC - Accreditation Information

Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Education Resources and Cardiometabolic Health Congress. Medical Education Resources is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Medical Education Resources designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAFP (American Academy of Family Physicians) Credit
This Live activity, Cardiometabolic Health Congress Regional Conference Series, from 05/07/2016 - 06/18/2016, has been reviewed and is acceptable for up to 6.50 Prescribed credits by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credit (ANCC)
Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This CE activity provides 6.75 contact hours of continuing nursing education.

Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 6.75 contact hours.

Registered Dietitian Credit
Medical Education Resources (Provider Number ME110) is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 6.5 continuing professional education units (CPEUs) for completion of this program/material.

Pharmacy Credit
Medical Education Resources (MER) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MER designates this continuing education activity for 6.75 contact hours (0.675 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Program Number ‐ 0816‐9999‐16‐065‐L01‐P)

This activity is certified as Knowledge‐based CPE.

Attention Certified Diabetes Educators: Best of CMHC is accredited by Medical Education Resources (MER). MER is accredited by the ACCME, ANCC, ACPE, and the CDR to provide continuing medical education. All of these accredited organizations are recognized by the AADE when applying for CDE renewal of certification or for initial certification.

Disclosure of Conflicts of Interest
It is the policy of Medical Education Resources (MER) to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a CME activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high‐quality activities that promote improvements or quality in health care and not the business interest of a commercial interest.

Statement of Need
The ever‐increasing presence of cardiometabolic risk continues to be a major challenge for health care providers in the United States. Current estimates suggest approximately 23% ‐ 38% of all U.S. adults have metabolic syndrome, a constellation of cardiometabolic risk factors, including excessive abdominal fat, insulin resistance, inflammation, dyslipidemia, and hypertension. Patients with multiple cardiometabolic risk factors have twice the likelihood of developing and dying from cardiovascular disease and more than seven times the risk of developing diabetes compared to those with no cardiometabolic risk factors. Cardiovascular disease already affects approximately 83.6 million U.S. adults (> 1 in 3) and is the leading cause of U.S. deaths; however, this CVD burden can be expected to increase.

This sampling of sobering statistics points to a rapidly growing epidemic of cardiovascular and metabolic disease and calls to the forefront the need for medical education focused on all aspects of cardiometabolic risk. The CMHC presents an especially valuable venue for this educational outreach with sessions fostering a collaborative, multidisciplinary approach to care.

The Cardiometabolic Health Congress will translate the latest cutting‐edge medical research into practical, clinical strategies for preventing, delaying, and managing cardiovascular and metabolic disorders. The goal is to provide the medical community with evidence‐based interventions to improve health outcomes and quality of life for the growing numbers of patients at increased cardiometabolic risk.

Purpose Statement

To improve patient outcomes through early identification and intervention strategies for patients with, or at risk of developing, diabetes and cardiovascular disease.

Target Audience & Learning Objectives

The CMHC is designed for advanced‐level clinicians responsible for the prevention, diagnosis, and management of cardiometabolic risk.

At the end of the congress, participants will be able to:

1. Explain the interrelationships among the various cardiometabolic risk factors, their impact on cardiovascular health, and their common comorbidities.
2. Translate evidence‐based strategies for prevention, screening, and treatment of cardiometabolic risk factors and their comorbidities to their clinical practice.
3. Identify which interventions, including lifestyle changes and various drugs in combination, are most appropriate for particular patients based on their risk profiles.
4. Identify how novel and emerging therapies can be integrated into clinical practice to reduce morbidity and mortality from cardiovascular and metabolic disease.
5. Apply a personalized medicine approach to incorporate biomarkers, imaging and therapies into individualized patient treatment plans.

Disclaimer

The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, Cardiometabolic Health Congress and/or the various industry supporters. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Medical Education Resources, Cardiometabolic Health Congress and/or the various industry supporters. MER's ANCC accreditation status does not imply endorsement by MER or ANCC of any commercial products displayed in conjunction with this activity. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

This activity is jointly provided by Tarsus Cardio Inc. dba Cardiometabolic Health Congress and Medical Education Resources (MER).